Kegg medicus dgroup
| DG02950 | |
| DG番号 | DG02950 |
| 分類 | DGroup |
| 名称 | FMO3 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | DG01395 Itopride D08094 Itopride (INN) D02729 Itopride hydrochloride (JAN) DG01283 Teneligliptin D08616 Teneligliptin (INN) D09756 Teneligliptin hydrobromide hydrate (JAN) D11968 Teneligliptin hydrobromide (JAN) DG00714 Dasatinib D03658 Dasatinib (JAN/INN) D06414 Dasatinib (USAN); Dasatinib hydrate (JAN) D12609 Dasatinib laurylsulfate (USAN) DG02968 Fedratinib D10630 Fedratinib (USAN/INN) D11296 Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN) D11406 Risdiplam (JAN/USAN/INN) DG00839 Almotriptan D02824 Almotriptan (USAN) D02825 Almotriptan malate (USP) D10897 Teneligliptin and canagliflozin |
| 上位グループ | Metabolizing enzyme substrate |
| 注釈1 | - |
| 注釈2 | - |